SCHEMBL29720759

SCHEMBL29720759

Cc1cnc(-c2nc(O)c3scc(-c4ccccn4)c3n2)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.42
CYP19A1 P11511 3/20 0.39
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.36
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
PKM P14618 2/20 0.35
PTK2 Q05397 1/20 0.35
KRAS P01116 1/20 0.35
HSD17B10 Q99714 2/20 0.35
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GFER P55789 2/20 0.34
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 1/20 0.33
KDM4C Q9H3R0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24127740 1.00 PDE10A (0.42) PDE10ACYP19A1KDM4EALDH1A1KMT2A
SCHEMBL20665754 0.83 KDM4E (0.49) PDE10ACYP19A1KDM4EALDH1A1RAB9A
SCHEMBL26038698 0.79 PDE10A (0.44) PDE10ACYP19A1KDM4EALDH1A1KMT2A
SCHEMBL24827580 0.78 PDE10A (0.45) PDE10ACYP19A1KDM4EALDH1A1KMT2A
SCHEMBL24128224 0.77 CYP2A6 (0.48) CYP19A1KDM4EALDH1A1GAARAB9A
SCHEMBL29720635 0.77 CYP2A6 (0.48) CYP19A1KDM4EALDH1A1GAARAB9A
SCHEMBL18997515 0.76 NPC1 (0.47) PDE10ACYP19A1KDM4EKMT2AGAA
SCHEMBL24128044 0.76 PRKCI (0.44) PDE10ACYP19A1KDM4EALDH1A1KMT2A
SCHEMBL29720453 0.76 PRKCI (0.44) PDE10ACYP19A1KDM4EALDH1A1KMT2A
SCHEMBL20665240 0.75 MEN1 (0.46) PDE10ACYP19A1KDM4EKMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4168414-A1 SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE Shy Therapeutics LLC (US) 2023-04-26 EP disclosed
WO-2021257828-A9 SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2022-07-21 WO disclosed